Lantern Pharma Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Lantern Pharma Inc
Did you know?
Capital expenditures decreased by 86% from FY24 to FY25.
Current Price
$2.23
+5.19%Profile
Valuation (TTM)
Market Cap$24.94M
P/E-1.46
EV—
P/B3.82
Shares Out11.18M
P/Sales—
Revenue$0.00
EV/EBITDA—
LTRN (LTRN) — Earnings Call Transcripts
No transcripts available yet
No earnings call transcripts are available for LTRN yet. Check back after the next earnings report.
← Back to LTRN overview